Discovery of novel covalent selective estrogen receptor degraders against endocrine-resistant breast cancer-Reference-Cited by-同舟云学术

Discovery of novel covalent selective estrogen receptor degraders against endocrine-resistant breast cancer

Published:2023-12 Issue:12 Volume:13 Page:4963-4982
ISSN:2211-3835
Container-title:Acta Pharmaceutica Sinica B
language:en
Short-container-title:Acta Pharmaceutica Sinica B

Author:

Wang Yubo,Min Jian,Deng Xiangping,Feng Tian,Hu Hebing,Guo Xinyi,Cheng Yan,Xie Baohua,Yang Yu,Chen Chun-Chi,Guo Rey-Ting^ORCID,Dong Chune,Zhou Hai-Bing

Funder

National Key Research and Development Program of China

Fundamental Research Funds for the Central Universities

China Postdoctoral Science Foundation

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics

Reference43 articles.

1. Cancer statistics;Siegel;Ca - Cancer J Clin,2020

2. Recent advances in the treatment of breast cancer;Tong;Front Oncol,2018

3. Incidence of breast cancer in the United States: current and future trends;Anderson;J Natl Cancer Inst,2011

4. Strategies for the discovery and development of therapies for metastatic breast cancer;Eckhardt;Nat Rev Drug Discov,2012

5. Estrogen receptors as therapeutic targets in breast cancer;Ariazi;Curr Top Med Chem,2006

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual-target inhibitors based on ERα: Novel therapeutic approaches for endocrine resistant breast cancer;European Journal of Medicinal Chemistry;2024-04

2. Fluorescence theranostic PROTACs for real-time visualization of ERα degradation;European Journal of Medicinal Chemistry;2024-03

3. New generation estrogen receptor-targeted agents in breast cancer: present situation and future prospectives;Acta Materia Medica;2024

4. X-ray crystallography study and optimization of novel benzothiophene analogs as potent selective estrogen receptor covalent antagonists (SERCAs) with improved potency and safety profiles;Bioorganic Chemistry;2023-12

5. Fluorescence Theranostic PROTACs for Real-Time Visualization of ERα Degradation;2023